Summary Basis for Regulatory Action

First Page		Document Content
Orphan drugs Transfusion medicine Idiopathic thrombocytopenic purpura Romiplostim Thrombocytopenia Intravenous immunoglobulin Rho(D) immune globulin Eltrombopag Platelet Medicine Biology Blood		Summary Basis for Regulatory Action Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 331,47 KB Share Document on Facebook

	IP Internship project 2: Characterization of IgG dimers/polymers in therapeutic immune globulin preparations Introduction: Patients who are immunoglobulin deficient receive intravenous immunoglobulin (IVIG). People with DocID: 1ssOE - View Document
	Product Monograph Cytogam® CYTOMEGALOVIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMAN) Liquid Formulation, Solvent Detergent Treated DocID: 1qbBc - View Document
	Kristen Weaver is determined to live a healthy life and "become more in touch with the connection between my body and mind." Living the “FULLEST LIFE POSSIBLE” DocID: 1gfLb - View Document
	Intravenous Immunoglobulin Francisco Kerdel & Luis Dehesa C DocID: 1ahv4 - View Document
	Thin Endometrium: The Connection to Chemical Pregnancy and Unexplained Infertility While there is no officially accepted definition of “thin lining”, a measurement of the endometrial lining less than 8mm on the day DocID: 196A4 - View Document